The James McGill Professor of Biomedical Ethics will talk about: “Clinical Trials of New Drugs: Do Patients Benefit from Participating in Clinical Trials?”
Symposium on Rare Diseases with keynotes, lectures and a panel discussion with Michael Hund (EB Research Partnership), Tobias Cantz (MHH) as well as Christopher Baum and Peter N. Robinson of the BIH.